We sought to investigate differential phenotypic characteristics according to neutrophil counts, using a biostatistics approach in a large-cohort study from the Spanish Online Bronchiectasis Registry (RIBRON). The 1034 patients who met the inclusion criteria were clustered into two groups on the basis of their blood neutrophil levels. Using the Mann–Whitney U test to explore potential differences according to FACED and EFACED scores between the two groups, a neutrophil count of 4990 cells/µL yielded the most balanced cluster sizes: (1) above-threshold (n = 337) and (2) below-threshold (n = 697) groups. Patients above the threshold showed significantly worse lung function parameters and nutritional status, while systemic inflammation levels ...
Rationale: Bronchiectasis is classically considered a neutrophilic disorder, but eosinophilic subtyp...
A group of bronchiectatic subjects in the clinically stable state were studied for systemic evidence...
Altres ajuts: Fondo Europeo de Desarrollo Regional (FEDER); CIBERES; SEPAR 2020; ZAMBON-PHARMA, Spai...
We sought to investigate differential phenotypic characteristics according to neutrophil counts, usi...
We sought to investigate differential phenotypic characteristics according to neutrophil counts, usi...
We sought to investigate differential phenotypic characteristics according to neutrophil counts, usi...
We sought to investigate differential phenotypic characteristics according to neutrophil counts, usi...
Differential phenotypic characteristics using data mining approaches were defined in a large cohort ...
Differential phenotypic characteristics using data mining approaches were defined in a large cohort ...
Whether high blood eosinophil counts may define a better phenotype in bronchiectasis patients, as sh...
Whether high blood eosinophil counts may define a better phenotype in bronchiectasis patients, as sh...
Whether high blood eosinophil counts may define a better phenotype in bronchiectasis patients, as sh...
Most patients with bronchiectasis have a predominantly neutrophilic inflammatory profile, although o...
Bronchiectasis is a heterogeneous disease. This study aimed at identifying discrete groups of patien...
RATIONALE: Although inflammation and infection are key disease drivers in bronchiectasis, few studie...
Rationale: Bronchiectasis is classically considered a neutrophilic disorder, but eosinophilic subtyp...
A group of bronchiectatic subjects in the clinically stable state were studied for systemic evidence...
Altres ajuts: Fondo Europeo de Desarrollo Regional (FEDER); CIBERES; SEPAR 2020; ZAMBON-PHARMA, Spai...
We sought to investigate differential phenotypic characteristics according to neutrophil counts, usi...
We sought to investigate differential phenotypic characteristics according to neutrophil counts, usi...
We sought to investigate differential phenotypic characteristics according to neutrophil counts, usi...
We sought to investigate differential phenotypic characteristics according to neutrophil counts, usi...
Differential phenotypic characteristics using data mining approaches were defined in a large cohort ...
Differential phenotypic characteristics using data mining approaches were defined in a large cohort ...
Whether high blood eosinophil counts may define a better phenotype in bronchiectasis patients, as sh...
Whether high blood eosinophil counts may define a better phenotype in bronchiectasis patients, as sh...
Whether high blood eosinophil counts may define a better phenotype in bronchiectasis patients, as sh...
Most patients with bronchiectasis have a predominantly neutrophilic inflammatory profile, although o...
Bronchiectasis is a heterogeneous disease. This study aimed at identifying discrete groups of patien...
RATIONALE: Although inflammation and infection are key disease drivers in bronchiectasis, few studie...
Rationale: Bronchiectasis is classically considered a neutrophilic disorder, but eosinophilic subtyp...
A group of bronchiectatic subjects in the clinically stable state were studied for systemic evidence...
Altres ajuts: Fondo Europeo de Desarrollo Regional (FEDER); CIBERES; SEPAR 2020; ZAMBON-PHARMA, Spai...